Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui K Gan

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Neuro-Oncology Practice|March 27, 2023
MGMT methylation: Is it time to embrace the shades of grey?Hui K Gan
Neuro-Oncology Practice|May 23, 2022
Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settingsSagun Parakh, Hui K Gan
Targeted Oncology|March 8, 2019
BI 853520, a FAK-Simile of Prior FAK Inhibitors?Rachael Chang Lee, Hui K Gan
Current Opinion in Pharmacology|June 9, 2018
Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseasesUmbreen Hafeez, Hui K Gan, Andrew M Scott
Expert Opinion on Investigational Drugs|May 21, 2009
Sunitinib in solid tumorsHui K Gan, Bostjan Seruga, Jennifer J Knox
Expert Review of Anticancer Therapy|November 10, 2009
Low-grade oligodendroglioma: current treatments and future hopesZarnie Lwin, Hui K Gan, Warren P Mason
New Biotechnology|April 9, 2011
Antibodies in oncologyVinochani Pillay, Hui K Gan, Andrew M Scott
Critical Reviews in Oncogenesis|January 19, 2021
Sensitization of Cancers Resistant to HER2 AntibodiesSagun Parakh, Hui K Gan, Andrew M Scott
The FEBS Journal|June 20, 2013
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are alteredHui K Gan, Anna N Cvrljevic, Terrance G Johns
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 28, 2009
The EGFRvIII variant in glioblastoma multiformeHui K Gan, Andrew H Kaye, Rodney B Luwor
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Neuro-Oncology Practice|March 27, 2023
MGMT methylation: Is it time to embrace the shades of grey?Hui K Gan
Neuro-Oncology Practice|May 23, 2022
Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settingsSagun Parakh, Hui K Gan
Targeted Oncology|March 8, 2019
BI 853520, a FAK-Simile of Prior FAK Inhibitors?Rachael Chang Lee, Hui K Gan
Current Opinion in Pharmacology|June 9, 2018
Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseasesUmbreen Hafeez, Hui K Gan, Andrew M Scott
Expert Opinion on Investigational Drugs|May 21, 2009
Sunitinib in solid tumorsHui K Gan, Bostjan Seruga, Jennifer J Knox
Expert Review of Anticancer Therapy|November 10, 2009
Low-grade oligodendroglioma: current treatments and future hopesZarnie Lwin, Hui K Gan, Warren P Mason
New Biotechnology|April 9, 2011
Antibodies in oncologyVinochani Pillay, Hui K Gan, Andrew M Scott
Critical Reviews in Oncogenesis|January 19, 2021
Sensitization of Cancers Resistant to HER2 AntibodiesSagun Parakh, Hui K Gan, Andrew M Scott
The FEBS Journal|June 20, 2013
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are alteredHui K Gan, Anna N Cvrljevic, Terrance G Johns
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 28, 2009
The EGFRvIII variant in glioblastoma multiformeHui K Gan, Andrew H Kaye, Rodney B Luwor
Pageof 14